Real-World Experience With Oral Tranexamic Acid and Lasers for Pigmentary Disorders: A 5-Year Safety Review

Dermatol Surg. 2021 Sep 1;47(9):1303-1304. doi: 10.1097/DSS.0000000000003122.
No abstract available

MeSH terms

  • Antifibrinolytic Agents / administration & dosage*
  • Combined Modality Therapy
  • Face*
  • Female
  • Humans
  • Laser Therapy / methods*
  • Male
  • Middle Aged
  • Patient Safety*
  • Pigmentation Disorders / therapy*
  • Tranexamic Acid / administration & dosage*

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid